Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

Gleevec decreases cancer recurrence for GIST

Preliminary results from a large, randomized, placebo-controlled clinical trial for patients with primary gastrointestinal stromal tumor (GIST), a type of tumor usually found in the stomach or small intestine, showed that patients who received imatinib mesylate (Gleevec) after complete removal of their tumor were significantly less likely to have a recurrence of their cancer compared to those who did not receive imatinib.

15 Apr 2007

Serious side effects from large amounts of niacin

Taking excessive doses of a common vitamin in an attempt to defeat drug screening tests may send the user to the hospital -- or worse.

5 Apr 2007

FDA issues Salmonella alert for Pet Chews - potential for cross contamination, in people, especially children

The Food and Drug Administration (FDA) today warned consumers not to use American Bullie A.B. Bull Pizzle Puppy Chews and Dog Chews manufactured and distributed by T.W. Enterprises, Ferndale, WA, because they have the potential to be contaminated with Salmonella, which can cause serious infections in dogs and cats, and, if there is cross contamination, in people, especially children, the aged, and people with compromised immune systems.

5 Apr 2007

Combination of sumatriptan and naproxen sodium for migraine more effective than single medications

Combining two different types of treatment for migraine results in better symptom relief than taking either one of the medications, according to a study in the April 4 issue of JAMA .

4 Apr 2007

Ropinirole reduces "off" time in Parkinson's

Parkinson disease patients taking the drug, ropinirole 24-hour prolonged release significantly reduced their daily "off" time in which Parkinson's symptoms like tremor, slowness, stiffness, and walking difficulty return as drugs wear off, according to a study published in the April 3, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

4 Apr 2007

Multimechanism-targeted therapy for migraine more effective than single medications

Combining two different types of treatment for migraine results in better symptom relief than taking either one of the medications, according to a study in the April 4 issue of JAMA.

3 Apr 2007

Study results on bifeprunox in patients with schizophrenia

Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week.

2 Apr 2007

Performing x-rays using iodine dye increases risk for kidney failure

Performing x-rays using iodine dye places patients with impaired kidney function at increased risk for kidney failure. Known as Contrast-Induced Nephropathy (ne-FROPP-a- thee) or ''CIN,'' this complication is the third most common cause of hospital-acquired kidney failure in the United States and Europe, accounting for 10-12 percent of all such cases.

1 Apr 2007

FDA warning on mineral water containing arsenic

The Food and Drug Administration (FDA) is re-issuing its warning to consumers not to drink "Jermuk" brand mineral water due to the risk of exposure to arsenic, a toxic substance and a known cause of cancer in humans.

25 Mar 2007

FDA clears Xpert EV test for meningitis

The U.S. Food and Drug Administration (FDA) has cleared for marketing a test that uses molecular biology to quickly detect the presence of viral meningitis.

19 Mar 2007

Tykerb (lapatinib) - new anti-cancer treatment approved

The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).

14 Mar 2007

Study aims to find which breast cancer patients need chemotherapy

Most postmenopausal women with small breast tumors don't need chemotherapy to reduce their recurrence risk after lumpectomy.

13 Mar 2007

FDA warning on mineral water from Armenia

The Food and Drug Administration (FDA) is warning consumers not to drink certain brands of mineral water imported from Armenia due to the risk of exposure to arsenic, a toxic substance and known cause of cancer in humans.

8 Mar 2007

Sunny days pose risk of 'flicker illness' for a few airlifted patients

"This shouldn't preclude transporting a patient from point A to point B in an aircraft, but this concern does need to register as a legitimate risk for a small number of patients. Personnel ought to know how to guard against it."

8 Mar 2007

Arm yourself with knowledge before plastic surgery

Despite the fact that 8 out of 10 patients who have plastic surgery are happy with the results, nearly 40 percent wish they had done better research before the operation with regard to the potential side effects and complications.

6 Mar 2007

FDA investigating norovirus linked to San Antonio Bay oysters

The U.S. Food and Drug Administration (FDA) is investigating an outbreak of norovirus-associated illness linked to eating raw oysters harvested from San Antonio Bay, TX.

4 Mar 2007

FDA approves Humira (adalimumab) for Crohn's disease

The U.S. Food and Drug Administration (FDA) today approved Humira (adalimumab) to treat adult patients with moderately to severely active Crohn's disease, a chronic inflammatory disease of the intestines, which affects an estimated one million Americans.

27 Feb 2007

FDA approves antidepressant Cymbalta (duloxetine HCl) for treatment of generalized anxiety disorder

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.

26 Feb 2007

CDC says Gardasil's side effects minor

CDC officials on Thursday plan to present data at a meeting in Atlanta showing that 542 adverse health complaints have been reported about Merck's human papillomavirus vaccine Gardasil, but agency officials said the side effects of the vaccine are minor and that the vaccine does not require additional warning labels, the AP/Long Island Newsday reports .

25 Feb 2007

Gardasil reaction report released

The National Vaccine Information Center (NVIC) today released a new analysis of the federal Vaccine Adverse Event Reporting System (VAERS) reports of serious health problems following HPV vaccination (Merck's Gardasil) during the last six months of 2006.

21 Feb 2007